Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
Kelly D. Moynihan, Cary F. Opel, Gregory L. Szeto, et al.
Nature Medicine (2016) Vol. 22, Iss. 12, pp. 1402-1410
Open Access | Times Cited: 485

Showing 1-25 of 485 citing articles:

Delivery technologies for cancer immunotherapy
Rachel Riley, Carl H. June, Róbert Langer, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 3, pp. 175-196
Open Access | Times Cited: 2122
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
Yuanyuan Zhang, Zemin Zhang
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 8, pp. 807-821
Open Access | Times Cited: 1990
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo González, Catharina Hagerling, Zena Werb
Genes & Development (2018) Vol. 32, Iss. 19-20, pp. 1267-1284
Open Access | Times Cited: 1735
Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1599
Therapeutic cancer vaccines
Mansi Saxena, Sjoerd H. van der Burg, Cornelis J.M. Melief, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 6, pp. 360-378
Closed Access | Times Cited: 1076
Therapeutic cancer vaccines
Cornelis J.M. Melief, Thorbald van Hall, Ramon Arens, et al.
Journal of Clinical Investigation (2015) Vol. 125, Iss. 9, pp. 3401-3412
Open Access | Times Cited: 1033
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai, Lukasz J. Ochyl, Keith S. Bahjat, et al.
Nature Materials (2016) Vol. 16, Iss. 4, pp. 489-496
Open Access | Times Cited: 931
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Zhuting Hu, Patrick A. Ott, Catherine J. Wu
Nature reviews. Immunology (2017) Vol. 18, Iss. 3, pp. 168-182
Open Access | Times Cited: 889
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Eryn Blass, Patrick A. Ott
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 4, pp. 215-229
Open Access | Times Cited: 738
Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine
Nathan D. Donahue, Handan Acar, Stefan Wilhelm
Advanced Drug Delivery Reviews (2019) Vol. 143, pp. 68-96
Closed Access | Times Cited: 734
Progress in tumor-associated macrophage (TAM)-targeted therapeutics
Chayanon Ngambenjawong, Heather H. Gustafson, Suzie H. Pun
Advanced Drug Delivery Reviews (2017) Vol. 114, pp. 206-221
Open Access | Times Cited: 691
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
Daniel Shae, Kyle W. Becker, Plamen P. Christov, et al.
Nature Nanotechnology (2019) Vol. 14, Iss. 3, pp. 269-278
Open Access | Times Cited: 545
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
John D. Martin, Horacio Cabral, Triantafyllos Stylianopoulos, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 4, pp. 251-266
Open Access | Times Cited: 537
CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions
Masao Hashimoto, Alice O. Kamphorst, Se Jin Im, et al.
Annual Review of Medicine (2018) Vol. 69, Iss. 1, pp. 301-318
Open Access | Times Cited: 534
Improving cancer immunotherapy through nanotechnology
Michael S. Goldberg
Nature reviews. Cancer (2019) Vol. 19, Iss. 10, pp. 587-602
Closed Access | Times Cited: 524
In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy
Chao Wang, Jinqiang Wang, Xudong Zhang, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 429
Open Access | Times Cited: 512
Biology and regulation of IL-2: from molecular mechanisms to human therapy
Rosanne Spolski, Peng Li, Warren J. Leonard
Nature reviews. Immunology (2018) Vol. 18, Iss. 10, pp. 648-659
Closed Access | Times Cited: 478
Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response
Oh Youn Kim, Hyun Taek Park, Nhung Thi Hong Dinh, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 460
Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors
Rachel Grosser, Leonid Cherkassky, Navin K. Chintala, et al.
Cancer Cell (2019) Vol. 36, Iss. 5, pp. 471-482
Open Access | Times Cited: 405
A facile approach to enhance antigen response for personalized cancer vaccination
Aileen W. Li, Miguel C. Sobral, S Badrinath, et al.
Nature Materials (2018) Vol. 17, Iss. 6, pp. 528-534
Open Access | Times Cited: 371
Enhanced CAR–T cell activity against solid tumors by vaccine boosting through the chimeric receptor
Leyuan Ma, Tanmay Dichwalkar, Jason Y.H. Chang, et al.
Science (2019) Vol. 365, Iss. 6449, pp. 162-168
Open Access | Times Cited: 361
A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
Tingting Wang, Dangge Wang, Haijun Yu, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 355
Bridging Bio–Nano Science and Cancer Nanomedicine
Mattias Björnmalm, Kristofer J. Thurecht, Michael Michael, et al.
ACS Nano (2017) Vol. 11, Iss. 10, pp. 9594-9613
Open Access | Times Cited: 352
Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2
Krzysztof M. Zak, P. Grudnik, Katarzyna Magiera‐Mularz, et al.
Structure (2017) Vol. 25, Iss. 8, pp. 1163-1174
Open Access | Times Cited: 329
Neutrophil-Based Drug Delivery Systems
Dafeng Chu, Xinyue Dong, Xutong Shi, et al.
Advanced Materials (2018) Vol. 30, Iss. 22
Open Access | Times Cited: 314
Page 1 - Next Page

Scroll to top